Skip to content
Company Analysis

Neogen Corporation NEOG

A comprehensive view of key metrics, scores, and financial health for Neogen Corporation

Overview of Neogen Corporation

NEOG NMS
Healthcare Diagnostics & Research Framework: Medical Devices & Diagnostics Mid Cap
Neogen Corporation (NEOG), is a Mid Cap company, in the Diagnostics & Research industry, last closed at $11.88, about 49.2% overvalued vs fair value, +116.1% 1Y return, ranked 517/1145 in sector.
Metrics Gross Margin 46.9%
USD 11.89
0.46%
(Delayed)
• Vol 90d: 52.0%
52-Week Range
Market Cap
$2.12B
Enterprise Value
$2.73B
Overall Score
View breakdown
Overall
Growth
Weak
Profitability
Fair
Health
Fair
Efficiency
Fair
Valuation
Good
Growth
Weak
Profitability
Fair
Health
Fair
Efficiency
Fair
Valuation
Good
Completeness: 100%
Confidence: 60%
Updated: Sep 12
Top Beats

Quick Facts

Website https://www.neogen.com
HQ Lansing, MI
Employees 2,974
Fiscal year May 31

Next Events

Earnings Oct 8 Estimated

Fair Value Snapshot

Bear Base Bull
$5
$6
$7
Current: $11.89 -49% vs base

Engine Room Money Flow™

Mid Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$870.4M
-2.7%%
Gross Profit
$408.5M
-3.1%%
Operating Income (GAAP)
$-21.6M
-1170.6%%
EBITDA
$170.5M
118.2%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
46.9%
Fair

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
5
Active Leaks
4/5
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Neogen Corporation's durable competitive advantages across 6 defense dimensions

Overall Moat Strength
50
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Stable Gross Margin Profile Gross margin stability is strong (score 0.78). Low volatility confirms durable consumable pricing.
  • Durable Capital Returns ROIC durability is strong (score 0.82). Consistent returns confirm the moat is not eroding.

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.37). May indicate commodity-like product mix or distributor margin drag.
  • Thin Interest Coverage Interest coverage lags peers (score 0.35). Thin coverage limits M&A optionality and raises refinancing risk.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
54
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Generic Industrial / Default vs Industry Peers 92% Coverage
Trade-Off Triangle Visualization A ternary plot showing NEOG's balance between Growth (28.7%), Profitability (36.7%), and Safety (34.6%). Growth 29% Safety 35% Profitability 37%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

34th percentile vs peers
35
Key Signals
Revenue CAGR 3Y 19.3% 72p Rev Growth YoY -3.2% 26p EPS Growth YoY -114.69 0p
Strengths
  • Debt/FCF Ratio in top 20% of peers (-19.29, 97th percentile)
  • Strong liquidity position vs peers
Risks
  • EPS Growth YoY in bottom 20% of peers (-114.69)

Profitability

44th percentile vs peers
44
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

41th percentile vs peers
42
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Neogen Corporation.

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$6.04
- - -
-49.2% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000